JPMorgan Chase & Co. (NYSE:JPM) had its price target raised by analysts at Morgan Stanley from $214.00 to $221.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Morgan Stanley’s target price would suggest a potential upside of 7.84% from the stock’s current price.
Other equities analysts have also recently issued reports about the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $211.00 target price on shares of JPMorgan Chase & Co. in a research note on Tuesday, May 21st. Jefferies Financial Group lifted their price objective on shares of JPMorgan Chase & Co. from $230.00 to $239.00 and gave the stock a “buy” rating in a research note on Wednesday, July 3rd. Wells Fargo & Company lifted their price objective on shares of JPMorgan Chase & Co. from $200.00 to $220.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 20th. Wolfe Research cut shares of JPMorgan Chase & Co. from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 8th. Finally, BMO Capital Markets lifted their price objective on shares of JPMorgan Chase & Co. from $195.00 to $205.00 and gave the stock a “market perform” rating in a research note on Thursday. Eight research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $199.56.
View Our Latest Analysis on JPM
JPMorgan Chase & Co. Stock Down 1.2 %
JPMorgan Chase & Co. (NYSE:JPM – Get Free Report) last posted its earnings results on Friday, July 12th. The financial services provider reported $6.12 earnings per share for the quarter, beating the consensus estimate of $4.19 by $1.93. The company had revenue of $50.80 billion during the quarter, compared to analysts’ expectations of $42.23 billion. JPMorgan Chase & Co. had a net margin of 20.32% and a return on equity of 17.52%. During the same period last year, the company posted $4.37 earnings per share. Sell-side analysts expect that JPMorgan Chase & Co. will post 16.5 EPS for the current fiscal year.
Insider Transactions at JPMorgan Chase & Co.
In other news, CEO Mary E. Erdoes sold 15,895 shares of JPMorgan Chase & Co. stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $193.66, for a total value of $3,078,225.70. Following the transaction, the chief executive officer now owns 585,898 shares of the company’s stock, valued at approximately $113,465,006.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other JPMorgan Chase & Co. news, General Counsel Stacey Friedman sold 4,415 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $200.65, for a total transaction of $885,869.75. Following the sale, the general counsel now owns 42,124 shares of the company’s stock, valued at approximately $8,452,180.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Mary E. Erdoes sold 15,895 shares of the stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $193.66, for a total transaction of $3,078,225.70. Following the completion of the sale, the chief executive officer now owns 585,898 shares of the company’s stock, valued at $113,465,006.68. The disclosure for this sale can be found here. Insiders have sold a total of 72,343 shares of company stock valued at $14,137,789 in the last 90 days. Insiders own 0.79% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Capital International Investors lifted its position in shares of JPMorgan Chase & Co. by 1.9% during the first quarter. Capital International Investors now owns 42,294,992 shares of the financial services provider’s stock worth $8,471,687,000 after purchasing an additional 778,297 shares in the last quarter. Norges Bank acquired a new stake in shares of JPMorgan Chase & Co. during the fourth quarter worth about $6,016,878,000. Capital World Investors lifted its position in shares of JPMorgan Chase & Co. by 0.4% during the first quarter. Capital World Investors now owns 34,422,011 shares of the financial services provider’s stock worth $6,894,729,000 after purchasing an additional 150,812 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of JPMorgan Chase & Co. by 3.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 21,338,704 shares of the financial services provider’s stock worth $3,629,757,000 after purchasing an additional 695,502 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of JPMorgan Chase & Co. by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 20,170,399 shares of the financial services provider’s stock worth $3,389,329,000 after purchasing an additional 154,426 shares in the last quarter. Hedge funds and other institutional investors own 71.55% of the company’s stock.
JPMorgan Chase & Co. Company Profile
JPMorgan Chase & Co operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking.
Read More
- Five stocks we like better than JPMorgan Chase & Co.
- How Can Investors Benefit From After-Hours Trading
- CPI Data Sparks Rally in Biotech Stocks
- P/E Ratio Calculation: How to Assess Stocks
- High Call Option Volume: 3 Stocks to Keep on Your Radar
- Conference Calls and Individual Investors
- Positive News is Driving This Cancer Drug Maker’s Stock Higher
Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.